Differentiating PD from ET funding announcement for biomarkers



Differential diagnosis of PD from other parkinsonian disorders, such as Essential Tremor (ET), Multiple System Atrophy (MSA), Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP), can be clinically challenging, particularly during the early disease stages. There is no definitive biomarker for PD or for other atypical neurodegenerative parkinsonian disorders during life. This FOA seeks to better fill these scientific gaps.

Katrina A Gwinn MD


WatchMarch 14, 2016 – Last week I received a telephone call from Pakistan. The caller, from Trequant, explained that they were trying to increase awareness of a device they are developing. It is identical to and worn as a wristwatch. As I could see real potential for Essential Tremor, I forwarded information on the device & organization to Dr. Dietrich Haubenberger at NIH. He responded to me that it merited attention. I have subsequently facilitated direct contact between Dr. Haubenberger & Trequant. I will keep you updated on further developments.